newsfilter
← Latest News
Business Wire·

Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the fourth quarter and year ending December 31, 2025 on Thursday, February